HUP0500993A2 - Vakcinakészítmény és eljárás alkalmazására - Google Patents

Vakcinakészítmény és eljárás alkalmazására

Info

Publication number
HUP0500993A2
HUP0500993A2 HU0500993A HUP0500993A HUP0500993A2 HU P0500993 A2 HUP0500993 A2 HU P0500993A2 HU 0500993 A HU0500993 A HU 0500993A HU P0500993 A HUP0500993 A HU P0500993A HU P0500993 A2 HUP0500993 A2 HU P0500993A2
Authority
HU
Hungary
Prior art keywords
same
vaccine composition
vaccine
composition
Prior art date
Application number
HU0500993A
Other languages
English (en)
Inventor
Gilad Gallili
Norbert Frydman
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of HUP0500993A2 publication Critical patent/HUP0500993A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
HU0500993A 2001-02-28 2002-02-28 Vakcinakészítmény és eljárás alkalmazására HUP0500993A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/795,792 US6592869B2 (en) 1999-08-24 2001-02-28 Vaccine composition and method of using the same
PCT/IB2002/001944 WO2002067846A2 (en) 2001-02-28 2002-02-28 A vaccine composition and method of using the same

Publications (1)

Publication Number Publication Date
HUP0500993A2 true HUP0500993A2 (hu) 2007-08-28

Family

ID=25166460

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0500993A HUP0500993A2 (hu) 2001-02-28 2002-02-28 Vakcinakészítmény és eljárás alkalmazására

Country Status (8)

Country Link
US (2) US6592869B2 (hu)
EP (1) EP1370285A4 (hu)
CA (1) CA2438956A1 (hu)
CZ (1) CZ20032617A3 (hu)
HU (1) HUP0500993A2 (hu)
IL (1) IL157609A0 (hu)
WO (1) WO2002067846A2 (hu)
ZA (1) ZA200306573B (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3213700A (en) * 1999-01-29 2000-08-18 Sharper Image Corporation A rack for compact discs
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
WO2005021056A1 (en) * 2003-08-21 2005-03-10 Cns, Inc. Effervescent delivery system
US20050196455A1 (en) * 2003-10-27 2005-09-08 Jianbing Chen Suspension delivery system for the sustained and controlled local release of pharmaceuticals
WO2005061088A1 (en) * 2003-12-22 2005-07-07 Finlay Warren H Powder formation by atmospheric spray-freeze drying
WO2007014073A2 (en) * 2005-07-22 2007-02-01 Amgen Inc. Concentrated protein lyophilates, methods, and uses
DE102006054260A1 (de) * 2006-02-28 2007-09-27 Lohmann Animal Health Gmbh & Co. Kg Wasser stabilisierende Zusammensetzung, Verfahren zu deren Herstellung und deren Verwendung
WO2008147847A1 (en) * 2007-05-22 2008-12-04 Baylor College Of Medicine Immune complex vaccination as a strategy to enhance immunity in the elderly and other immune compromised populations
GB2450117A (en) * 2007-06-13 2008-12-17 Reckitt Benckiser Healthcare A water- and oxygen-occlusive blister tablet pack
GB2451428A (en) * 2007-07-25 2009-02-04 Pliva Hrvatska D O O Process for preparing an in ovo combination viral vaccine
EP2163239A1 (de) * 2008-05-27 2010-03-17 Qiagen GmbH Produkte, die Biopartikel enthalten, Verfahren zu ihrer Herstellung
MX2011003277A (es) * 2008-10-14 2012-09-21 Salubrious Pharmaceuticals LLC Proceso para el tratamiento de la artritis reumatoide, temblores/enfermedad de parkinson, esclerosis multiple y cancer de tipo no viral.
US20110110975A1 (en) * 2009-11-06 2011-05-12 Streck, Inc. Inactivated virus compositions and methods of preparing such compositions
EA201390810A1 (ru) 2010-12-02 2013-09-30 Онколитикс Байотек Инк. Жидкие вирусные составы
CN103269716B (zh) 2010-12-02 2015-05-27 昂科利蒂克斯生物科技公司 冻干病毒制剂
WO2012123269A1 (en) 2011-03-11 2012-09-20 Proyecto De Biomedicina Cima, S.L. Immunogenic compositions and methods for their use
WO2012151391A2 (en) 2011-05-04 2012-11-08 Streck, Inc. Inactivated virus compositions and methods of preparing such compositions
TWI745278B (zh) * 2014-10-10 2021-11-11 以色列商艾畢克生物實驗有限公司 發泡性降低之疫苗組合物

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE289201C (hu)
DE106660C (hu)
DE289200C (hu)
DE298202C (hu)
DE117250C (hu)
GB929377A (en) 1961-02-09 1963-06-19 Carl Peter Varnet Foot and mouth disease implantation preparations
US3317393A (en) 1964-06-08 1967-05-02 Robert M Chanock Immunization by selective infection of the intestinal tract with an encapsulated live virus
US3458621A (en) 1966-08-31 1969-07-29 American Home Prod Tablet dosage-form for the immunization of the intestinal tract with live virus preparations
US3603030A (en) 1969-08-29 1971-09-07 Remco Ind Inc Jumping toy
FR2082760A5 (en) 1970-03-26 1971-12-10 France Etat Aerosol immunisation appts - for freeze-dried vaccines
US3893280A (en) 1972-06-21 1975-07-08 Burns Biotec Lab Inc Transfer packaging for biologicals
DE2237783A1 (de) 1972-08-01 1974-02-14 Bayern Freistaat Impfstoffzubereitung zur oralen pocken-impfung
BE853923A (fr) 1977-04-25 1977-10-25 Rit Rech Ind Therapeut Nouveau vaccin vivant ameliore contre le pseudopeste aviaire et son procede de preparation
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4251509A (en) * 1980-01-31 1981-02-17 Wisconsin Alumni Research Foundation Dry particulate vaccine for oral administration
US4458630A (en) 1982-06-22 1984-07-10 The United States Of America As Represented By The Secretary Of Agriculture Disease control in avian species by embryonal vaccination
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
IE61575B1 (en) 1987-05-04 1994-11-16 Merck & Co Inc A stable lyophilized live herpes virus vaccine
US5710014A (en) * 1988-02-11 1998-01-20 The United States Of America As Represented By The Department Of Health And Human Services Cloned cDNA for human procathepsin l.
US5472710A (en) 1988-04-16 1995-12-05 Schwarz Pharma Ag Pharmaceutical preparation to be administered orally with controlled release of active substance and method for its manufacture
US5350741A (en) 1988-07-30 1994-09-27 Kanji Takada Enteric formulations of physiologically active peptides and proteins
ES2097155T3 (es) 1989-10-02 1997-04-01 Cima Labs Inc Forma de dosificacion efervescente y metodo de administracion.
ATE150976T1 (de) * 1989-10-02 1997-04-15 Univ Arkansas Impfstoff-konjugate zur behandlung von vogelkrankheiten
US5091188A (en) 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
FR2662942B1 (fr) 1990-06-06 1992-09-18 Neway Tsehay Medicament immunostimulant a base de glycopeptidolipides polaires de mycobacterium chelonae.
US5178882A (en) 1990-06-22 1993-01-12 The Regents Of The University Of California Viral decoy vaccine
NZ286242A (en) 1991-03-26 1997-11-24 Csl Ltd Use of veterinary implant as a single dose vaccination system: rupturable polymer film coating around core of active agent and water soluble excipient
US5206219A (en) 1991-11-25 1993-04-27 Applied Analytical Industries, Inc. Oral compositions of proteinaceous medicaments
MX9303992A (es) * 1992-07-06 1995-01-31 Harvard College Mutantes de eliminacion como vacunas para el colera.
WO1994017813A1 (en) 1993-02-08 1994-08-18 Paravax, Inc. Defective sindbis virus vectors that express toxoplasma gondii p30 antigens
US5709861A (en) * 1993-04-22 1998-01-20 Emisphere Technologies, Inc. Compositions for the delivery of antigens
EP0725789B1 (en) * 1993-09-20 2003-03-19 Anadis Ltd. Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition
US5595761A (en) 1994-01-27 1997-01-21 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving tablet
US5576014A (en) 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
US5635210A (en) * 1994-02-03 1997-06-03 The Board Of Regents Of The University Of Oklahoma Method of making a rapidly dissolving tablet
CN1097619C (zh) 1994-07-12 2003-01-01 伯温德药品服务公司 隔潮膜涂层组合物及其生产方法以及涂层制品
RU2122429C1 (ru) * 1995-11-16 1998-11-27 Говоров Виктор Тимофеевич Способ изготовления сухой вакцины преимущественно против болезни ньюкасла
IL120202A (en) 1996-03-07 2001-03-19 Akzo Nobel Nv Container with freeze-dried vaccine components
US5912014A (en) 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
EP0914141A1 (en) * 1996-04-22 1999-05-12 Peter R. Rothschild Stabilized antihepatitis-b vaccine tablets
US5710041A (en) 1996-06-03 1998-01-20 Remel L.P. In situ reconstitutable lyophylized bacteria ampoule package
HRP970493A2 (en) 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
AU4133397A (en) * 1996-10-28 1998-05-22 Pfizer Inc. Oral vaccines for young animals with an enteric coating
DE19741114C2 (de) 1997-09-12 2002-10-24 Riemser Arzneimittel Ag Feuchtigkeitsstabile und magensaftresistente Arzneiform für Fische
CU22700A1 (es) 1997-09-29 2001-07-31 Ct Ingenieria Genetica Biotech Formulación farmacéutica anti-viral que contiene un péptido de la proteína factor anti-lps de limulus y su uso
GB9722682D0 (en) 1997-10-27 1997-12-24 Scherer Ltd R P Pharmaceutical products
GB9801870D0 (en) 1998-01-28 1998-03-25 Raby Limited Vaccine composition
CA2362260C (en) * 1999-02-16 2009-05-12 Michael A. Taylor Single dose delivery device
AP1768A (en) * 1999-08-17 2007-08-16 Smithkline Beecham Biologicals S A Vaccine
PT1212045T (pt) * 1999-08-24 2016-11-22 Abic Biological Laboratories Ltd Composição de vacina e método de utilização da mesma
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same

Also Published As

Publication number Publication date
US7192588B2 (en) 2007-03-20
US20030026813A1 (en) 2003-02-06
IL157609A0 (en) 2004-03-28
WO2002067846A8 (en) 2003-10-09
ZA200306573B (en) 2006-10-25
US20030059435A1 (en) 2003-03-27
EP1370285A4 (en) 2005-04-13
US6592869B2 (en) 2003-07-15
WO2002067846A3 (en) 2003-03-13
CA2438956A1 (en) 2002-09-06
CZ20032617A3 (cs) 2004-08-18
EP1370285A2 (en) 2003-12-17
WO2002067846A2 (en) 2002-09-06

Similar Documents

Publication Publication Date Title
AU2002357119A8 (en) Mitocidal compositions and methods
AU2002364528A8 (en) Bio-implant and method of making the same
EP1423120A4 (en) 2H-PHTALAZINE-1-ONES AND METHODS OF USE THEREOF
PL374106A1 (en) Vaccine composition
GB0128287D0 (en) Novel method and compounds
IL148247A0 (en) A vaccine composition and method of using the same
EP1455793A4 (en) ANTI-DIABETAL FORMULATION AND METHOD
ZA200306573B (en) A vaccine composition and method of using the same
EP1434772A4 (en) CONNECTIONS AND METHODS
HU0104832D0 (en) Cosmetic composition and method
AU2002357748A8 (en) Osteopontin-related compositions and methods
GB0126643D0 (en) Composition and process
AU2002359694A8 (en) Compounds and methods
EP1379240A4 (en) CONNECTIONS AND METHODS
GB0113869D0 (en) Plaster composition and method of making the same
GB2371575B (en) Cementing tool and method
AU2002359869A8 (en) Pak5-related compositions and methods
GB0107033D0 (en) Method and composition
GB0111734D0 (en) Composition and method
GB0130030D0 (en) Composition and method
GB0121627D0 (en) Method and composition
GB0114332D0 (en) Plaster composition and method of making the same
GB0114555D0 (en) Plaster composition and method of making the same
GB0114539D0 (en) Plaster composition and method of making the same
GB0114504D0 (en) Plaster composition and method of making the same

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: ABIE BIOLOGICAL LABORATORIES LTD., IL

Free format text: FORMER OWNER(S): TEVA PHARMACEUTICAL INDUSTRIES, LTD., IL

FC4A Lapse of provisional application due to refusal